| Drug-Eluting Stent | Bare Metal Stent | PValue |
---|---|---|---|
N | 19,103 | 16,335 | Â |
Age (years) | 64.1 | 63.2 | < 0.001 |
Male Sex (%) | 70.8 | 70.6 | 0.72 |
Race/Ethnicity (%) | Â | Â | < 0.001 |
   Asian | 9.8 | 7.0 |  |
   Black | 5.3 | 5.3 |  |
   Hispanic | 9.4 | 8.4 |  |
   White, non-Hispanic | 65.8 | 72.1 |  |
   Other | 9.7 | 7.3 |  |
Comorbidities (%) | Â | Â | Â |
   Diabetes | 33.8 | 26.2 | < 0.001 |
   Hypertension | 68.5 | 49.6 | < 0.001 |
   Prior MI | 13.0 | 11.1 | < 0.001 |
   PCI Indication: |  |  | < 0.001 |
STEMI | 16.0 | 27.5 | Â |
NSTEMI | 28.0 | 19.3 | Â |
Stable or unstable angina | 57.3 | 54.8 | Â |
   Prior PCI | 19.1 | 14.1 | < 0.001 |
   Prior CABG | 5.7 | 5.3 | 0.12 |
   Congestive Heart Failure | 4.6 | 3.4 | < 0.001 |
   Prior Stroke | 1.6 | 1.2 | 0.005 |
   Peripheral Arterial Disease | 4.3 | 3.3 | < 0.001 |
   Glomerular Filtration Rate |  |  | < 0.001 |
> 90 | 15.0 | 16.2 | Â |
60 - 89 | 39.7 | 33.4 | Â |
30 - 59 | 21.5 | 15.2 | Â |
15 - 30 | 1.9 | 1.3 | Â |
< 15 or HD | 0.7 | 0.5 | Â |
Unknown | 21.1 | 33.3 | Â |
   Systemic Malignancy | 5.7 | 5.8 | 0.75 |
   Prior Gastrointestinal Bleeding | 2.3 | 1.8 | < 0.001 |
   Chronic Lung Disease | 18.3 | 21.9 | < 0.001 |
Medications | Â | Â | Â |
   β-Blockers | 50.0 | 40.1 | < 0.001 |
   Clopidogrel | 12.7 | 6.3 | < 0.001 |
   Statin | 51.7 | 34.8 | < 0.001 |
   ACE-I/ARB | 41.9 | 27.8 | < 0.001 |
   Warfarin | 3.8 | 3.0 | < 0.001 |